121
Views
7
CrossRef citations to date
0
Altmetric
Editorial

High-density lipoprotein and innate immunity

, &
Pages 729-734 | Published online: 18 Jan 2017

  • Navab M, Anantharamaiah GM, Fogelman AM: The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15, 158–161 (2005).
  • Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A: HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161, 1–16 (2002).
  • Rifkin MR: Identification of trypanocidal factor in normal human-serum – highdensity lipoprotein. Proc. Natl Acad. Sci. USA 75, 3450–3454 (1978).
  • Hajduk SL, Moore DR, Vasudevacharya J et al.: Lysis of Trypanosoma brucei by a toxic subspecies of human high-density lipoprotein. J. Biol. Chem. 264, 5210–5217 (1989).
  • Lugli EB, Pouliot M, Portela MDM, Loomis MR, Raper J: Characterization of primate trypanosome lytic factors. Mol. Biochem. Parasitol. 138, 9–20 (2004).
  • Raper J, Fung R, Ghiso J, Nussenzweig V, Tomlinson S: Characterization of a novel trypanosome lytic factor from human serum. Infect. Immun. 67, 1910–1916 (1999).
  • Smith AB, Esko JD, Hajduk SL: Killing of trypanosomes by the human haptoglobinrelated protein. Science 268, 284–286 (1995).
  • Tomlinson S, Muranjan M, Nussenzweig V, Raper J: Haptoglobin-related protein and apolipoprotein AI are components of the two trypanolytic factors in human serum. Mol. Biochem. Parasitol. 86, 117–120 (1997).
  • Muranjan M, Nussenzweig V, Tomlinson S: Characterization of the human serum trypanosome toxin, haptoglobin-related protein. J. Biol. Chem. 273, 3884–3887 (1998).
  • Madsen M, Graversen JH, Moestrup SK: Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes. Redox Rep. 6, 386–388 (2001).
  • Kristiansen M, Graversen JH, Jacobsen C et al.: Identification of the haemoglobin scavenger receptor. Nature 409, 198–201 (2001).
  • Balestrieri M, Cigliano L, De Simone ML, Dale B, Abrescia P: Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid. Mol. Reprod. Dev. 59, 186–191 (2001).
  • Cigliano L, Spagnuolo MS, Dale B, Balestrieri M, Abrescia P: Estradiol esterification in the human preovulatory follicle. Steroids 66, 889–896 (2001).
  • Kunitake ST, Carilli CT, Lau K, Protter AA, Nayavigne J, Kane JP: Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption. Biochemistry 33, 1988–1993 (1994).
  • Spagnuolo MS, Cigliano L, D’Andrea LD, Pedone C, Abrescia P: Assignment of the binding site for haptoglobin on apolipoprotein A-I. J. Biol. Chem. 280, 1193–1198 (2005).
  • Porta A, Cassano E, Balestrieri M et al.: Haptoglobin transport into human ovarian follicles and its binding to apolipoprotein A-1. Zygote 7, 67–77 (1999).
  • Maeda N: Nucleotide-sequence of the haptoglobin and haptoglobin-related gene pair – the haptoglobin-related gene contains a retrovirus-like element. J. Biol. Chem. 260, 6698–6709 (1985).
  • Mcevoy SM, Maeda N: Complex events in the evolution of the haptoglobin gene-cluster in primates. J. Biol. Chem. 263, 15740–15747 (1988).
  • Shiflett AM, Bishop JR, Pahwa A, Hajduk SL: Human high density lipoproteins are platforms for the assembly of multicomponent innate immune complexes. J. Biol. Chem. 280, 32578–32585 (2005).
  • Nielsen MJ, Petersen SV, Jacobsen C et al.: Haptoglobin-related protein is a highaffinity hemoglobin-binding plasma protein. Blood 108, 2846–2849 (2006).
  • Drain J, Bishop JR, Hajduk SL: Haptoglobinrelated protein mediates trypanosome lytic factor binding to trypanosomes. J. Biol. Chem. 276, 30254–30260 (2001).
  • Page NM, Butlin DJ, Lomthaisong K, Lowry PJ: The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. Genomics 74, 71–78 (2001).
  • Monajemi H, Fontijn RD, Pannekoek H, Horrevoets AJG: The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. Genomics 79, 539–546 (2002).
  • Duchateau PN, Pullinger CR, Orellana RE et al.: Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas – identification, cloning, characterization, and plasma distribution of apolipoprotein L. J. Biol. Chem. 272, 25576–25582 (1997).
  • Molina-Portela MP, Lugli EB, Recio-Pinto E, Raper J: Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cationselective pores in membranes. Mol. Biochem. Parasitol. 144, 218–226 (2005).
  • Pays E, Vanhollebeke B, Vanhamme L, Paturiaux-Hanocq F, Nolan DP, Perez-Morga D: The trypanolytic factor of human serum. Nat. Rev. Microbiol. 4, 477–486 (2006).
  • Perez-Morga D, Vanhollebeke B, Paturiaux-Hanocq F et al.: Apolipoprotein L-1 promotes trypanosome lysis by forming pores in lysosomal membranes. Science 309, 469–472 (2005).
  • Hager KM, Pierce MA, Moore DR, Tytler EM, Esko JD, Hajduk SL: Endocytosis of a cytotoxic human highdensity- lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of african trypanosomes. J. Cell Biol. 126, 155–167 (1994).
  • Shimamura M, Hager KM, Hajduk SL: The lysosomal targeting and intracellular metabolism of trypanosome lytic factor by Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 115, 227–237 (2001).
  • Raper J, Portela MPM, Lugli E, Frevert U, Tomlinson S: Trypanosome lytic factors: novel mediators of human innate immunity. Curr. Opin. Microbiol. 4, 402–408 (2001).
  • Poelvoorde P, Vanhamme L, van den Abbeele J, Switzer WM, Pays E: Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera. Mol. Biochem. Parasitol. 134, 155–157 (2004).
  • Baral TN, Magez S, Stijlemans B et al.: Experimental therapy of African trypanosomiasis with a nanobodyconjugated human trypanolytic factor. Nat. Med. 12, 580–584 (2006).
  • Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P et al.: Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature 422, 83–87 (2003).
  • De Greef C, Hamers R: The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein. Mol. Biochem. Parasitol. 68, 277–284 (1994).
  • Xong HV, Vanhamme L, Chamekh M et al.: AVSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense. Cell 95, 839–846 (1998).
  • Hatada S, Seed JR, Barker C, Hajduk SL, Black S, Maeda N: No trypanosome lytic activity in the sera of mice producing human haptoglobin-related protein. Mol. Biochem. Parasitol. 119, 291–294 (2002).
  • Raper J, Nussenzweig V, Tomlinson S: The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein. J. Exp. Med. 183, 1023–1029 (1996).
  • Bishop JR, Shimamura M, Hajduk SL: Insight into the mechanism of trypanosome lytic factor-1 killing of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 118, 33–40 (2001).
  • Portela MPM, Raper J, Tomlinson S: An investigation into the mechanism of trypanosome lysis by human serum factors. Mol. Biochem. Parasitol. 110, 273–282 (2000).
  • Smith AB, Hajduk SL: Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum. Proc. Natl Acad. Sci. USA 92, 10262–10266 (1995).
  • Barker C, Barbour KW, Berger FG, Hajduk SL: Activity of human trypanosome lytic factor in mice. Mol. Biochem. Parasitol. 117, 129–136 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.